TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7677751
log Bayes Factor = 0.367058
Chromosome 4   position 55,124,460  (GRCh37) Explore rs7677751 on Ensembl!
Variant rs7677751 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
I35.0 Aortic (valve) stenosis
0.561 0.439 0.000
I35 Nonrheumatic aortic valve disorders
0.094 0.906 0.000
I35.8 Other aortic valve disorders
0.072 0.928 0.000
I35.2 Aortic (valve) stenosis with insufficiency
0.059 0.941 0.000
G95.9 Disease of spinal cord, unspecified
0.000 0.942 0.058
I35.9 Aortic valve disorder, unspecified
0.057 0.943 0.000
G95 Other diseases of spinal cord
0.000 0.944 0.056
G95.2 Cord compression, unspecified
0.000 0.947 0.053
G95.8 Other specified diseases of spinal cord
0.000 0.948 0.052
E11 Non-insulin-dependent diabetes mellitus
0.050 0.950 0.000
E11.5 With peripheral circulatory complications
0.048 0.952 0.000
E11.8 With unspecified complications
0.048 0.952 0.000
E11.1 With ketoacidosis
0.046 0.954 0.000
E11.3 With ophthalmic complications
0.045 0.955 0.000
E11.2 With renal complications
0.044 0.956 0.000
E11.9 Without complications
0.043 0.957 0.000
G95.0 Syringomyelia and syringobulbia
0.000 0.959 0.041
E11.7 With multiple complications
0.036 0.964 0.000
G90-G99 Other disorders of the nervous system
0.000 0.965 0.035
G93 Other disorders of brain
0.000 0.967 0.033
E11.0 With coma
0.032 0.968 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.000 0.968 0.032
I35.1 Aortic (valve) insufficiency
0.031 0.969 0.000
G93.9 Disorder of brain, unspecified
0.000 0.969 0.031
E11.6 With other specified complications
0.030 0.969 0.000
G95.1 Vascular myelopathies
0.000 0.971 0.029
G97.1 Other reaction to spinal and lumbar puncture
0.000 0.971 0.029
G93.4 Encephalopathy, unspecified
0.000 0.972 0.028
G98 Other disorders of nervous system, not elsewhere classified
0.000 0.974 0.026
G93.1 Anoxic brain damage, not elsewhere classified
0.000 0.974 0.026
G93.0 Cerebral cysts
0.000 0.974 0.026
G96 Other disorders of central nervous system
0.000 0.974 0.026
G93.2 Benign intracranial hypertension
0.000 0.974 0.026
E11.4 With neurological complications
0.026 0.974 0.000
G92 Toxic encephalopathy
0.000 0.975 0.025
G94 Other disorders of brain in diseases classified elsewhere
0.000 0.975 0.025
G97.0 Cerebrospinal fluid leak from spinal puncture
0.000 0.975 0.025
G93.7 Reye's syndrome
0.000 0.976 0.024
G93.5 Compression of brain
0.000 0.976 0.024
G93.3 Postviral fatigue syndrome
0.000 0.976 0.024
B37.0 Candidal stomatitis
0.023 0.977 0.000
G97.8 Other postprocedural disorders of nervous system
0.000 0.977 0.023
G97.9 Postprocedural disorder of nervous system, unspecified
0.000 0.977 0.023
G97.2 Intracranial hypotension following ventricular shunting
0.000 0.977 0.023
G93.8 Other specified disorders of brain
0.000 0.978 0.022
G93.6 Cerebral oedema
0.000 0.979 0.021
G96.0 Cerebrospinal fluid leak
0.000 0.979 0.020
G90 Disorders of autonomic nervous system
0.000 0.980 0.020
B97.8 Other viral agents as the cause of diseases classified to other chapters
0.000 0.981 0.019
B97.7 Papillomavirus as the cause of diseases classified to other chapters
0.000 0.981 0.019
G96.9 Disorder of central nervous system, unspecified
0.000 0.981 0.019
G96.8 Other specified disorders of central nervous system
0.000 0.981 0.019
D03.3 Melanoma in situ of other and unspecified parts of face
0.019 0.981 0.000
G94.1 Hydrocephalus in neoplastic disease
0.000 0.981 0.019
G96.1 Disorders of meninges, not elsewhere classified
0.000 0.982 0.018
G94.8 Other specified disorders of brain in diseases classified elsewhere
0.000 0.982 0.018
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere
0.000 0.982 0.018
B97 Viral agents as the cause of diseases classified to other chapters
0.000 0.983 0.017
G94.2 Hydrocephalus in other diseases classified elsewhere
0.000 0.983 0.017
G90.3 Multisystem degeneration
0.000 0.983 0.016
B37 Candidiasis
0.017 0.983 0.000
G91 Hydrocephalus
0.000 0.984 0.016
G90.8 Other disorders of autonomic nervous system
0.000 0.985 0.015
G90.4 Autonomic dysreflexia
0.000 0.985 0.015
G90.1 Familial dysautonomia [Riley-Day]
0.000 0.985 0.015
D03 Melanoma in situ
0.014 0.986 0.000
G90.2 Horner's syndrome
0.000 0.986 0.014
B37.3 Candidiasis of vulva and vagina
0.014 0.986 0.000
B35-B49 Mycoses
0.013 0.987 0.000
B37.9 Candidiasis, unspecified
0.013 0.987 0.000
B97.6 Parvovirus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B97.5 Reovirus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B97.3 Retrovirus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B97.2 Coronavirus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B97.1 Enterovirus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B97.0 Adenovirus as the cause of diseases classified to other chapters
0.000 0.987 0.013
B44 Aspergillosis
0.013 0.987 0.000
D03.5 Melanoma in situ of trunk
0.013 0.987 0.000
B37.7 Candidal septicaemia
0.013 0.987 0.000
B37.2 Candidiasis of skin and nail
0.012 0.988 0.000
G99 Other disorders of nervous system in diseases classified elsewhere
0.000 0.988 0.012
G90.0 Idiopathic peripheral autonomic neuropathy
0.000 0.988 0.012
B37.6 Candidal endocarditis
0.012 0.988 0.000
B37.5 Candidal meningitis
0.012 0.988 0.000
B44.9 Aspergillosis, unspecified
0.012 0.988 0.000
G91.9 Hydrocephalus, unspecified
0.000 0.988 0.012
D03.7 Melanoma in situ of lower limb, including hip
0.012 0.988 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.012 0.988 0.000
G91.3 Posttraumatic hydrocephalus, unspecified
0.000 0.988 0.011
G90.9 Disorder of autonomic nervous system, unspecified
0.000 0.989 0.011
B37.4 Candidiasis of other urogenital sites
0.011 0.989 0.000
G91.2 Normal-pressure hydrocephalus
0.000 0.989 0.011
B49 Unspecified mycosis
0.011 0.989 0.000
D03.9 Melanoma in situ, unspecified
0.010 0.989 0.000
D03.8 Melanoma in situ of other sites
0.010 0.989 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.010 0.989 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.010 0.989 0.000
D03.0 Melanoma in situ of lip
0.010 0.989 0.000
G91.0 Communicating hydrocephalus
0.000 0.990 0.010
B44.1 Other pulmonary aspergillosis
0.010 0.990 0.000
B35 Dermatophytosis
0.010 0.990 0.000
B36 Other superficial mycoses
0.010 0.990 0.000
B37.1 Pulmonary candidiasis
0.010 0.990 0.000
B48 Other mycoses, not elsewhere classified
0.010 0.990 0.000
B47 Mycetoma
0.010 0.990 0.000
B46 Zygomycosis
0.010 0.990 0.000
B45 Cryptococcosis
0.010 0.990 0.000
B43 Chromomycosis and phaeomycotic abscess
0.010 0.990 0.000
B42 Sporotrichosis
0.010 0.990 0.000
B41 Paracoccidioidomycosis
0.010 0.990 0.000
B40 Blastomycosis
0.010 0.990 0.000
B39 Histoplasmosis
0.010 0.990 0.000
B38 Coccidioidomycosis
0.010 0.990 0.000
G91.8 Other hydrocephalus
0.000 0.990 0.009
B44.8 Other forms of aspergillosis
0.009 0.991 0.000
B44.7 Disseminated aspergillosis
0.009 0.991 0.000
B44.2 Tonsillar aspergillosis
0.009 0.991 0.000
B44.0 Invasive pulmonary aspergillosis
0.009 0.991 0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere
0.000 0.991 0.009
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere
0.000 0.991 0.009
D03.4 Melanoma in situ of scalp and neck
0.009 0.991 0.000
B35.3 Tinea pedis
0.008 0.991 0.000
Z91.5 Personal history of self-harm
0.000 0.991 0.009
G91.1 Obstructive hydrocephalus
0.000 0.992 0.008
B37.8 Candidiasis of other sites
0.008 0.992 0.000
E10-E14 Diabetes mellitus
0.008 0.992 0.000
B36.9 Superficial mycosis, unspecified
0.008 0.992 0.000
B35.9 Dermatophytosis, unspecified
0.008 0.992 0.000
B35.8 Other dermatophytoses
0.008 0.992 0.000
B35.6 Tinea cruris
0.008 0.992 0.000
B35.5 Tinea imbricata
0.008 0.992 0.000
B35.4 Tinea corporis
0.008 0.992 0.000
B35.2 Tinea manuum
0.008 0.992 0.000
B35.0 Tinea barbae and tinea capitis
0.008 0.992 0.000
B36.8 Other specified superficial mycoses
0.007 0.992 0.000
B36.3 Black piedra
0.007 0.992 0.000
B36.2 White piedra
0.007 0.992 0.000
B36.1 Tinea nigra
0.007 0.992 0.000
B36.0 Pityriasis versicolor
0.007 0.992 0.000
B38.9 Coccidioidomycosis, unspecified
0.007 0.993 0.000
B38.8 Other forms of coccidioidomycosis
0.007 0.993 0.000
B38.7 Disseminated coccidioidomycosis
0.007 0.993 0.000
B38.4 Coccidioidomycosis meningitis
0.007 0.993 0.000
B38.3 Cutaneous coccidioidomycosis
0.007 0.993 0.000
B38.2 Pulmonary coccidioidomycosis, unspecified
0.007 0.993 0.000
B38.1 Chronic pulmonary coccidioidomycosis
0.007 0.993 0.000
B38.0 Acute pulmonary coccidioidomycosis
0.007 0.993 0.000
B39.9 Histoplasmosis, unspecified
0.007 0.993 0.000
B39.5 Histoplasmosis duboisii
0.007 0.993 0.000
B39.4 Histoplasmosis capsulati, unspecified
0.007 0.993 0.000
B39.3 Disseminated histoplasmosis capsulati
0.007 0.993 0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified
0.007 0.993 0.000
B39.1 Chronic pulmonary histoplasmosis capsulati
0.007 0.993 0.000
B39.0 Acute pulmonary histoplasmosis capsulati
0.007 0.993 0.000
B40.9 Blastomycosis, unspecified
0.007 0.993 0.000
B40.8 Other forms of blastomycosis
0.007 0.993 0.000
B40.7 Disseminated blastomycosis
0.007 0.993 0.000
B40.3 Cutaneous blastomycosis
0.007 0.993 0.000
B40.2 Pulmonary blastomycosis, unspecified
0.007 0.993 0.000
B40.1 Chronic pulmonary blastomycosis
0.007 0.993 0.000
B40.0 Acute pulmonary blastomycosis
0.007 0.993 0.000
B41.9 Paracoccidioidomycosis, unspecified
0.007 0.993 0.000
B41.8 Other forms of paracoccidioidomycosis
0.007 0.993 0.000
B41.7 Disseminated paracoccidioidomycosis
0.007 0.993 0.000
B41.0 Pulmonary paracoccidioidomycosis
0.007 0.993 0.000
B42.9 Sporotrichosis, unspecified
0.007 0.993 0.000
B42.8 Other forms of sporotrichosis
0.007 0.993 0.000
B42.7 Disseminated sporotrichosis
0.007 0.993 0.000
B42.1 Lymphocutaneous sporotrichosis
0.007 0.993 0.000
B42.0 Pulmonary sporotrichosis
0.007 0.993 0.000
B43.9 Chromomycosis, unspecified
0.007 0.993 0.000
B43.8 Other forms of chromomycosis
0.007 0.993 0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst
0.007 0.993 0.000
B43.1 Phaeomycotic brain abscess
0.007 0.993 0.000
B43.0 Cutaneous chromomycosis
0.007 0.993 0.000
B45.9 Cryptococcosis, unspecified
0.007 0.993 0.000
B45.8 Other forms of cryptococcosis
0.007 0.993 0.000
B45.7 Disseminated cryptococcosis
0.007 0.993 0.000
B45.3 Osseous cryptococcosis
0.007 0.993 0.000
B45.2 Cutaneous cryptococcosis
0.007 0.993 0.000
B45.1 Cerebral cryptococcosis
0.007 0.993 0.000
B45.0 Pulmonary cryptococcosis
0.007 0.993 0.000
B46.9 Zygomycosis, unspecified
0.007 0.993 0.000
B46.8 Other zygomycoses
0.007 0.993 0.000
B46.5 Mucormycosis, unspecified
0.007 0.993 0.000
B46.4 Disseminated mucormycosis
0.007 0.993 0.000
B46.3 Cutaneous mucormycosis
0.007 0.993 0.000
B46.2 Gastro-intestinal mucormycosis
0.007 0.993 0.000
B46.1 Rhinocerebral mucormycosis
0.007 0.993 0.000
B46.0 Pulmonary mucormycosis
0.007 0.993 0.000
B47.9 Mycetoma, unspecified
0.007 0.993 0.000
B47.1 Actinomycetoma
0.007 0.993 0.000
B47.0 Eumycetoma
0.007 0.993 0.000
B48.8 Other specified mycoses
0.007 0.993 0.000
B48.7 Opportunistic mycoses
0.007 0.993 0.000
B48.4 Penicillosis
0.007 0.993 0.000
B48.3 Geotrichosis
0.007 0.993 0.000
B48.2 Allescheriasis
0.007 0.993 0.000
B48.1 Rhinosporidiosis
0.007 0.993 0.000
B48.0 Lobomycosis
0.007 0.993 0.000
G43.9 Migraine, unspecified
0.000 0.993 0.007
B35.1 Tinea unguium
0.007 0.993 0.000
F33.9 Recurrent depressive disorder, unspecified
0.000 0.994 0.006
E12 Malnutrition-related diabetes mellitus
0.006 0.994 0.000
S82.80 Fractures of other parts of lower leg (closed)
0.006 0.994 0.000
N20.1 Calculus of ureter
0.000 0.994 0.006
N72 Inflammatory disease of cervix uteri
0.006 0.994 0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases
0.001 0.994 0.005
E13 Other specified diabetes mellitus
0.005 0.995 0.000
E14 Unspecified diabetes mellitus
0.005 0.995 0.000
Y42.7 Androgens and anabolic congeners
0.005 0.995 0.000
I73.9 Peripheral vascular disease, unspecified
0.005 0.995 0.000
E12.9 Without complications
0.004 0.995 0.000
E12.8 With unspecified complications
0.004 0.995 0.000
E12.7 With multiple complications
0.004 0.995 0.000
E12.6 With other specified complications
0.004 0.995 0.000
E12.5 With peripheral circulatory complications
0.004 0.995 0.000
E12.4 With neurological complications
0.004 0.995 0.000
E12.3 With ophthalmic complications
0.004 0.995 0.000
E12.2 With renal complications
0.004 0.995 0.000
E12.1 With ketoacidosis
0.004 0.995 0.000
E12.0 With coma
0.004 0.995 0.000
E14.8 With unspecified complications
0.004 0.995 0.000
K81.9 Cholecystitis, unspecified
0.000 0.995 0.005
G99.2 Myelopathy in diseases classified elsewhere
0.000 0.996 0.004
D00-D09 In situ neoplasms
0.004 0.996 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.004 0.996 0.000
D04 Carcinoma in situ of skin
0.004 0.996 0.000
D04.3 Skin of other and unspecified parts of face
0.004 0.996 0.000
E13.8 With unspecified complications
0.004 0.996 0.000
E13.7 With multiple complications
0.004 0.996 0.000
E13.6 With other specified complications
0.004 0.996 0.000
E13.5 With peripheral circulatory complications
0.004 0.996 0.000
E13.4 With neurological complications
0.004 0.996 0.000
E13.3 With ophthalmic complications
0.004 0.996 0.000
E13.2 With renal complications
0.004 0.996 0.000
E13.1 With ketoacidosis
0.004 0.996 0.000
E13.0 With coma
0.004 0.996 0.000
E14.7 With multiple complications
0.004 0.996 0.000
E14.6 With other specified complications
0.004 0.996 0.000
E14.5 With peripheral circulatory complications
0.004 0.996 0.000
E14.4 With neurological complications
0.004 0.996 0.000
E14.2 Withrenal complications
0.004 0.996 0.000
E14.1 With ketoacidosis
0.004 0.996 0.000
E14.0 With coma
0.004 0.996 0.000
Y40.0 Penicillins
0.004 0.996 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.004 0.996 0.000
D04.4 Skin of scalp and neck
0.004 0.996 0.000
M54.39 Sciatica (Site unspecified)
0.000 0.996 0.004
D09 Carcinoma in situ of other and unspecified sites
0.004 0.996 0.000
Y42.5 Other oestrogens and progestogens
0.004 0.996 0.000
Y43.0 Antiallergic and antiemetic drugs
0.004 0.996 0.000
L03.2 Cellulitis of face
0.000 0.996 0.004
Y43 Primarily systemic agents
0.004 0.996 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.004 0.996 0.000
Y40 Systemic antibiotics
0.004 0.996 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.004 0.996 0.000
D04.5 Skin of trunk
0.004 0.996 0.000
E14.3 With ophthalmic complications
0.004 0.996 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.003 0.996 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.996 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.003 0.996 0.000
C84.5 Other and unspecified T-cell lymphomas
0.003 0.996 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.003 0.996 0.000
R52.1 Chronic intractable pain
0.000 0.996 0.004
E13.9 Without complications
0.003 0.997 0.000
Y48 Anaesthetics and therapeutic gases
0.003 0.997 0.000
Y40.8 Other systemic antibiotics
0.003 0.997 0.000
C84.4 Peripheral T-cell lymphoma
0.003 0.997 0.000
Y42.9 Other and unspecified hormone antagonists
0.003 0.997 0.000
Y42.4 Oral contraceptives
0.003 0.997 0.000
Y42.2 Antithyroid drugs
0.003 0.997 0.000
Y42.1 Thyroid hormones and substitutes
0.003 0.997 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.003 0.997 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.003 0.997 0.000
D04.9 Skin, unspecified
0.003 0.997 0.000
D04.8 Skin of other sites
0.003 0.997 0.000
D04.1 Skin of eyelid, including canthus
0.003 0.997 0.000
D04.0 Skin of lip
0.003 0.997 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.003 0.997 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
D01.0 Colon
0.003 0.997 0.000
D09.0 Bladder
0.003 0.997 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.003 0.997 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.003 0.997 0.000
D09.1 Other and unspecified urinary organs
0.003 0.997 0.000
Y47.1 Benzodiazepines
0.003 0.997 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.003 0.997 0.000
E14.9 Without complications
0.003 0.997 0.000
Y43.3 Other antineoplastic drugs
0.003 0.997 0.000
Y59 Other and unspecified vaccines and biological substances
0.003 0.997 0.000
Y58 Bacterial vaccines
0.003 0.997 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.003 0.997 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.003 0.997 0.000
Y43.4 Immunosuppressive agents
0.003 0.997 0.000
Y48.4 Anaesthetic, unspecified
0.003 0.997 0.000
Y44 Agents primarily affecting blood constituents
0.003 0.997 0.000
F33 Recurrent depressive disorder
0.000 0.997 0.003
D09.9 Carcinoma in situ, unspecified
0.003 0.997 0.000
D09.7 Carcinoma in situ of other specified sites
0.003 0.997 0.000
D09.3 Thyroid and other endocrine glands
0.003 0.997 0.000
D09.2 Eye
0.003 0.997 0.000
S20.8 Superficial injuries of other and unspecified parts of thorax
0.000 0.997 0.003
C84.0 Mycosis fungoides
0.003 0.997 0.000
Y53.4 Other laxatives
0.003 0.997 0.000
Z63.4 Disappearance and death of family member
0.000 0.997 0.003
Y46 Antiepileptics and anti-Parkinsonism drugs
0.003 0.997 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.003 0.997 0.000
D04.2 Skin of ear and external auricular canal
0.003 0.997 0.000
Y43.9 Primarily systemic agent, unspecified
0.003 0.997 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.003 0.997 0.000
Y43.6 Enzymes, not elsewhere classified
0.003 0.997 0.000
Y43.5 Acidifying and alkalising agents
0.003 0.997 0.000
Y43.2 Antineoplastic natural products
0.003 0.997 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.003 0.997 0.000
D01.9 Digestive organ, unspecified
0.003 0.997 0.000
D01.7 Other specified digestive organs
0.003 0.997 0.000
D01.5 Liver, gallbladder and bile ducts
0.003 0.997 0.000
D01.4 Other and unspecified parts of intestine
0.003 0.997 0.000
D01.3 Anus and anal canal
0.003 0.997 0.000
D01.2 Rectum
0.003 0.997 0.000
D01.1 Rectosigmoid junction
0.003 0.997 0.000
Y40.7 Antifungal antibiotics, systemically used
0.003 0.997 0.000
Y40.6 Rifamycins
0.003 0.997 0.000
Y40.5 Aminoglycosides
0.003 0.997 0.000
Y40.4 Tetracyclines
0.003 0.997 0.000
Y40.2 Chloramphenicol group
0.003 0.997 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.003 0.997 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.003 0.997 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.003 0.997 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.003 0.997 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.003 0.997 0.000
Y51.0 Anticholinesterase agents
0.003 0.997 0.000
D04.7 Skin of lower limb, including hip
0.003 0.997 0.000
L28.0 Lichen simplex chronicus
0.003 0.997 0.000
I73 Other peripheral vascular diseases
0.003 0.997 0.000
Y57 Other and unspecified drugs and medicaments
0.003 0.997 0.000
D04.6 Skin of upper limb, including shoulder
0.003 0.997 0.000
Y48.2 Other and unspecified general anaesthetics
0.003 0.997 0.000
N20 Calculus of kidney and ureter
0.000 0.997 0.003
D07.4 Penis
0.003 0.997 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.003 0.997 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.003 0.997 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.003 0.997 0.000
Y47.4 Bromine compounds
0.003 0.997 0.000
Y47.3 Paraldehyde
0.003 0.997 0.000
Y47.2 Chloral derivatives
0.003 0.997 0.000
Y47.0 Barbiturates, not elsewhere classified
0.003 0.997 0.000
Y49.5 Other antipsychotics and neuroleptics
0.003 0.997 0.000
Y40.3 Macrolides
0.003 0.997 0.000
N20.2 Calculus of kidney with calculus of ureter
0.000 0.997 0.003
Y48.5 Therapeutic gases
0.003 0.997 0.000
Y48.1 Parenteral anaesthetics
0.003 0.997 0.000
Y48.0 Inhaled anaesthetics
0.003 0.997 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.003 0.997 0.000
Y54.7 Agents affecting calcification
0.003 0.997 0.000
M89.55 Osteolysis (Pelvic region and thigh)
0.003 0.997 0.000
Y54.8 Agents affecting uric acid metabolism
0.003 0.997 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.003 0.997 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.000 0.997 0.003
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.997 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.997 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.997 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.997 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.997 0.000
C84.3 Lymphoepithelioid lymphoma
0.003 0.997 0.000
C84.2 T-zone lymphoma
0.003 0.997 0.000
C84.1 Sezary's diease
0.003 0.997 0.000
D00.2 Stomach
0.002 0.997 0.000
D00.1 Oesophagus
0.002 0.997 0.000
D02.4 Respiratory system, unspecified
0.002 0.997 0.000
D02.3 Other parts of respiratory system
0.002 0.997 0.000
D02.2 Bronchus and lung
0.002 0.997 0.000
D02.1 Trachea
0.002 0.997 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.997 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.997 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.997 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.997 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.997 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.997 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.997 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.003 0.997 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.002 0.997 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.002 0.997 0.000
Y53.7 Emetics
0.002 0.997 0.000
Y53.6 Antidiarrhoeal drugs
0.002 0.997 0.000
Y53.5 Digestants
0.002 0.997 0.000
Y53.3 Saline and osmotic laxatives
0.002 0.997 0.000
Y53.2 Stimulant laxatives
0.002 0.997 0.000
Y53.0 Histamine H2-receptor antagonists
0.002 0.997 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.003 0.997 0.000
Y40.9 Systemic antibiotic, unspecified
0.003 0.997 0.000
Y52 Agents primarily affecting the cardiovascular system
0.003 0.997 0.000
Y49.2 Other and unspecified antidepressants
0.002 0.997 0.000
Y56.9 Topical agent, unspecified
0.002 0.997 0.000
Y56.8 Other topical agents
0.002 0.997 0.000
Y56.7 Dental drugs, topically applied
0.002 0.997 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.002 0.997 0.000
Y56.5 Ophthalmological drugs and preparations
0.002 0.997 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.002 0.997 0.000
Y56.3 Emollients, demulcents and protectants
0.002 0.997 0.000
Y56.2 Local astringents and local detergents
0.002 0.997 0.000
Y56.1 Antipruritics
0.002 0.997 0.000
D00.0 Lip, oral cavity and pharynx
0.002 0.997 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.000 0.997 0.003
Y44.5 Thrombolytic drugs
0.002 0.997 0.000
Y54.9 Mineral salts, not elsewhere classified
0.002 0.997 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.002 0.997 0.000
Y54.4 Loop [high-ceiling] diuretics
0.002 0.997 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.002 0.997 0.000
Y54.0 Mineralocorticoids
0.002 0.997 0.000
D02.0 Larynx
0.002 0.997 0.000
N20.9 Urinary calculus, unspecified
0.000 0.997 0.003
Y48.3 Local anaesthetics
0.002 0.997 0.000
I31.3 Pericardial effusion (noninflammatory)
0.003 0.997 0.000
Y50.9 Central nervous system stimulant, unspecified
0.002 0.997 0.000
Y50.8 Other central nervous system stimulants
0.002 0.997 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.002 0.997 0.000
Y50.1 Opioid receptor antagonists
0.002 0.997 0.000
Y50.0 Analeptics
0.002 0.997 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.997 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.002 0.997 0.000
Y55.5 Anticommon cold drugs
0.002 0.997 0.000
Y55.4 Expectorants
0.002 0.997 0.000
Y55.3 Antitussives
0.002 0.997 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.002 0.997 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.002 0.997 0.000
Y55.0 Oxytocic drugs
0.002 0.997 0.000
Y58.9 Other and unspecified bacterial vaccines
0.002 0.997 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.002 0.997 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.002 0.997 0.000
Y58.5 Diphtheria vaccine
0.002 0.997 0.000
Y58.4 Tetanus vaccine
0.002 0.997 0.000
Y58.3 Plague vaccine
0.002 0.997 0.000
Y58.2 Cholera vaccine
0.002 0.997 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.002 0.997 0.000
Y58.0 BCG vaccine
0.002 0.997 0.000
Y59.9 Vaccine or biological substance, unspecified
0.002 0.997 0.000
Y59.8 Other specified vaccines and biological substances
0.002 0.997 0.000
Y59.3 Immunoglobulin
0.002 0.997 0.000
Y59.2 Protozoal vaccines
0.002 0.997 0.000
Y59.1 Rickettsial vaccines
0.002 0.997 0.000
Y59.0 Viral vaccines
0.002 0.997 0.000
M54.3 Sciatica
0.000 0.997 0.003
S49.9 Unspecified injury of shoulder and upper arm
0.000 0.997 0.002
Y44.9 Other and unspecified agents affecting blood constituents
0.002 0.997 0.000
Y44.7 Plasma substitutes
0.002 0.997 0.000
Y44.6 Natural blood and blood products
0.002 0.997 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.002 0.997 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.997 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.002 0.997 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.002 0.997 0.000
Y46.2 Hydantoin derivatives
0.002 0.997 0.000
M54.22 Cervicalgia (Cervical region)
0.000 0.998 0.002
F33.8 Other recurrent depressive disorders
0.000 0.998 0.002
F33.4 Recurrent depressive disorder, currently in remission
0.000 0.998 0.002
Y57.6 Other diagnostic agents
0.002 0.998 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.002 0.998 0.000
Y41.5 Antiviral drugs
0.002 0.998 0.000
Y41.4 Anthelminthics
0.002 0.998 0.000
Y41.3 Other antiprotozoal drugs
0.002 0.998 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.002 0.998 0.000
Y41.1 Antimycobacterial drugs
0.002 0.998 0.000
Y41.0 Sulphonamides
0.002 0.998 0.000
Y46.8 Antispasticity drugs
0.002 0.998 0.000
Y46.7 Anti-Parkinsonism drugs
0.002 0.998 0.000
Y46.5 Valproic acid
0.002 0.998 0.000
Y46.3 Deoxybarbiturates
0.002 0.998 0.000
Y46.1 Oxazolidinediones
0.002 0.998 0.000
Y46.0 Succinimides
0.002 0.998 0.000
K81.0 Acute cholecystitis
0.000 0.998 0.002
S82.8 Fractures of other parts of lower leg
0.002 0.998 0.000
D06 Carcinoma in situ of cervix uteri
0.002 0.998 0.000
D07.6 Other and unspecified male genital organs
0.002 0.998 0.000
D07.3 Other and unspecified female genital organs
0.002 0.998 0.000
D07.2 Vagina
0.002 0.998 0.000
D07.0 Endometrium
0.002 0.998 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.998 0.000
M54.29 Cervicalgia-Site unspe
0.000 0.998 0.002
M86.97 Osteomyelitis, unspecified (Ankle and foot)
0.002 0.998 0.000
I73.8 Other specified peripheral vascular diseases
0.002 0.998 0.000
I73.0 Raynaud's syndrome
0.002 0.998 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.002 0.998 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.000 0.998 0.002
Z63.0 Problems in relationship with spouse or partner
0.000 0.998 0.002
Y43.1 Antineoplastic antimetabolites
0.002 0.998 0.000
Y46.4 Iminostilbenes
0.002 0.998 0.000
Y57.7 Vitamins, not elsewhere classified
0.002 0.998 0.000
Y57.4 Pharmaceutical excipients
0.002 0.998 0.000
Y57.3 Alcohol deterrents
0.002 0.998 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.002 0.998 0.000
Y57.1 Lipotropic drugs
0.002 0.998 0.000
Y57.0 Appetite depressants [anorectics]
0.002 0.998 0.000
I73.1 Thromboangiitis obliterans [Buerger]
0.002 0.998 0.000
W29.9 Unspecified place
0.000 0.998 0.002
Y54.5 Other diuretics
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.